Ekso Bionics Holdings, Inc. Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

Note 8 - Goodwill and Intangible Assets (Tables)

Note 8 - Goodwill and Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2026

Notes Tables

Intangible Asset, Finite-Lived [Table Text Block]

		*March 31, 2026*
		*Initial Gross Carrying Amount*				*Accumulated Amortization*				*Accumulated Impairment*				*Net Carrying Amount*
Developed technology		$	2,310			$	(959	)		$	—			$	1,351
Trade name			2,310				N/A				(570	)			1,740
Intellectual property			460				(35	)			(180	)			245
Customer relationships			140				(58	)			—				82
Total intangible assets		$	5,220			$	(1,052	)		$	(750	)		$	3,418

		*December 31, 2025*
		*Initial Gross Carrying Amount*				*Accumulated Amortization*				*Accumulated Impairment*				*Net Carrying Amount*
Developed technology		$	2,310			$	(887	)		$	—			$	1,423
Trade name			2,310				N/A				(570	)			1,740
Intellectual property			460				(29	)			(180	)			251
Customer relationships			140				(54	)			—				86
Total intangible assets		$	5,220			$	(970	)		$	(750	)		$	3,500

Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense [Table Text Block]

Fiscal Year		*Amount*
2026 - remainder		$	247
2027			330
2028			330
2029			330
2030			307
2031 and thereafter			134
Total		$	1,678